Location History:
- Amsterdam Zuidoost, NL (2018)
- Amsterdam, NL (2013 - 2020)
Company Filing History:
Years Active: 2013-2020
Title: Etsuko Yasuda: Innovator in RSV-Specific Binding Molecules
Introduction
Etsuko Yasuda is a prominent inventor based in Amsterdam, Netherlands. She has made significant contributions to the field of biotechnology, particularly in the development of antibodies targeting respiratory syncytial virus (RSV). With a total of 9 patents to her name, Yasuda's work has the potential to impact therapeutic approaches for viral infections.
Latest Patents
Yasuda's latest patents include groundbreaking inventions such as RSV-specific binding molecules and methods for producing them. The first invention provides antibodies and functional equivalents capable of specifically binding to RSV, along with the means and methods for their production. The second patent focuses on nucleic acid sequences encoding these antibodies, as well as the antibody-producing cells and methods for their generation. These innovations represent a significant advancement in the fight against RSV.
Career Highlights
Throughout her career, Etsuko Yasuda has worked with notable companies in the biotechnology sector. She has been associated with Medimmune Limited and Aimm Therapeutics B.V., where she has contributed her expertise in antibody development and production. Her work has been instrumental in advancing the understanding and treatment of viral infections.
Collaborations
Yasuda has collaborated with esteemed colleagues, including Tim Beaumont and Adrianus Quirinus Bakker. These partnerships have fostered innovation and have been crucial in the development of her patented technologies.
Conclusion
Etsuko Yasuda's contributions to the field of biotechnology, particularly in the development of RSV-specific binding molecules, highlight her role as a leading inventor. Her patents and collaborations reflect her commitment to advancing medical science and improving therapeutic options for viral infections.